论文部分内容阅读
在阿米巴病高度流行的墨西哥城的一个团体中选择13例阿米巴肝脓肿病人,在入院时及治愈出院10天后,应用游走抑制因子(MIF)及迟发型皮肤反应等试验进行检查,以探查阿米巴肝脓肿病人在侵袭期和治愈后的细胞免疫。同时以16名健康人为对照。 13例病人均经临床和实验室诊断为阿米巴肝脓肿的住院药人。16例健康人对照是经3次粪便检查及血清学检查均为阴性者。皮肤试验:在入院时用溶组织内阿米巴抗原作皮内注射,13例阿米巴肝脓肿病人中
Thirteen patients with amoebic hepatic abscess were selected from a group in Mexico City with a high prevalence of amoebiasis and were tested with walk-in suppression factor (MIF) and delayed-type skin reactions 10 days after admission and cured To investigate the cellular immunity of amoebic liver abscess patients during invasion and after cure. At the same time to 16 healthy people as a control. Thirteen patients were clinically and routinely diagnosed as inpatients with amoebic liver abscess. Sixteen healthy controls were negative after three stool tests and serological tests. Skin test: Entamoeba histolytica antigen was injected intradermally at admission, and in 13 patients with amoebic hepatic abscess